This binding activates downstream transcription factors such as LXRα, LXRβ, and PPARγ, which suppress inflammatory signaling pathways in macrophages (78, 79), thereby inhibiting the inflammatory response and preventing the continued development of IBD. The gene discussed is PPARG; the disease is inflammatory bowel disease.